1. Alberti, S., M. Nutini, and L.A. Herzenberg. 1994. DNA methylation prevents the amplification of TROP1, a tumour-associated cell surface antigen gene. Proc. Natl. Acad. Sci. U. S. A. 91:5833–5837.
2. Albor, A., and M. Kulesz-Martin. 2000. p53 and the Development of Genomic Instability: Possible Role of Topoisomerase I Interaction. In DNA Alterations in Cancer: Genetic and Epigenetic Alterations. M. Ehrlich, editor. Eaton Publishing, Natick. 409–422.
3. Aparicio, A., and J.S. Weber. 2002. Review of the clinical experience with 5-azacytidine and 5-aza-2′-deoxycytidine in solid tumours. Curr. Opin. Investig. Drugs. 3:627–633.
4. Bachman, K.E., M.R. Rountree, and S.B. Baylin. 2001. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 276:32282–32287.
5. Baylin, S.B. 2004. Reversal of gene silencing as a therapeutic target for cancer—roles for DNA methylation and its interdigitation with chromatin. Novartis Found Symp. 259:226–233; discussion 234–237, 285–238.